Oncotarget

Research Papers:

Vitexin induces apoptosis by suppressing autophagy in multi-drug resistant colorectal cancer cells

Monika Bhardwaj, Hee Jun Cho, Souren Paul, Rekha Jakhar, Imran Khan, Seon-Jin Lee, Bo-Yeon Kim, Manigandan Krishnan, Tejinder Pal Khaket, Hee Gu Lee and Sun Chul Kang _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2018; 9:3278-3291. https://doi.org/10.18632/oncotarget.22890

Metrics: PDF 1462 views  |   HTML 2896 views  |   ?  


Abstract

Monika Bhardwaj1,*, Hee Jun Cho2,*, Souren Paul1, Rekha Jakhar1, Imran Khan1, Seon-Jin Lee2,3, Bo-Yeon Kim3,4, Manigandan Krishnan1, Tejinder Pal Khaket1, Hee Gu Lee2,3 and Sun Chul Kang1

1Department of Biotechnology, Daegu University, Kyoungsan, Kyoungbook, Republic of Korea

2Immunotherapy Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea

3Department of Biomolecular Science, University of Science and Technology (UST), Daejeon, Republic of Korea

4World Class Institute, Anticancer Agents Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Cheongwon, Republic of Korea

*These authors contributed equally to this work

Correspondence to:

Sun Chul Kang, email: sckang@daegu.ac.kr

Hee Gu Lee, email: hglee@kribb.re.kr

Keywords: apoptosis; autophagy; colorectal cancer; multidrug resistance; vitexin

Received: October 02, 2017     Accepted: November 15, 2017     Published: December 04, 2017

ABSTRACT

Cancer treatment is limited due to the diverse multidrug resistance acquired by cancer cells and the collateral damage caused to adjacent normal cells by chemotherapy. The flavonoid compound vitexin exhibits anti-oxidative, anti-inflammatory and anti-tumor activity. This study elucidated the antitumor effects of vitexin and its underlying mechanisms in a multi-drug resistant human colon cancer cell line (HCT-116DR), which exhibits higher levels of multidrug-resistant protein 1 (MDR1) expression as compared with its parental cell line (HCT-116). Here, we observed that vitexin suppressed MDR-1 expression and activity in HCT-116DR cells and showed cytotoxic effect in HCT-116DR cells by inhibiting autophagy and inducing apoptosis in a concentration-dependent manner. Additionally, vitexin treatment caused cleavage of caspase-9 and caspase-3, and upregulated the expression of the pro-apoptotic proteins, BID and Bax. Moreover, the expression of autophagy-related proteins, such as ATG5, Beclin-1 and LC3-II, was markedly reduced by vitexin treatment. Furthermore, in vivo experiments showed that vitexin induced apoptosis and suppressed tumor growth in HCT-116DR xenograft model. These results revealed that vitexin induced apoptosis through suppression of autophagy in vitro and in vivo and provide insight into the therapeutic potential of vitexin for the treatment of chemo-resistant colorectal cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 22890